Study guide

11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

Certified Specialist in Poison Information CSPI

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacology & Toxicology Principles

1.1 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination Alterations in Overdose 1.2 Toxicodynamics, Receptor Pharmacology, and Dose-Response Relationships 1.3 Cellular and Biochemical Mechanisms of Toxicity 1.4 Hepatic Biotransformation, Phase I/II Reactions, and CYP450 Interactions

2 Chapter 2: Poison Center Case Assessment Fundamentals

2.1 Exposure History: The Questions That Change Management 2.2 Toxicologic Calculations: Doses, Concentrations, and Conversions

3 Chapter 3: Analgesics, Opioids & Over-the-Counter Medications

3.1 Acetaminophen Overdose: Pathophysiology, Rumack-Matthew Nomogram, and NAC Protocols 3.2 Salicylates: Pathophysiology, Acid-Base Derangements, and Urinary Alkalinization 3.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Miscellaneous OTC Analgesics 3.4 Opioids, Opioid Toxidrome, and Naloxone Titration 3.5 Cough and Cold Products, Antihistamines, Muscle Relaxants, and Local Anesthetics

4 Chapter 4: Psychotropic & Neurologic Medications

4.1 Tricyclic and Cyclic Antidepressants: Cardiotoxicity, ECG Findings, and Bicarbonate Therapy 4.2 SSRIs, SNRIs, Novel Antidepressants, and Serotonin Syndrome 4.3 Antipsychotics, Neuroleptic Malignant Syndrome, and Lithium Neurotoxicity 4.4 Benzodiazepines, Z-drugs, Barbiturates, and Major Anticonvulsants

5 Chapter 5: Cardiovascular Drugs & Substances of Abuse

5.1 Beta-Blockers, Calcium Channel Blockers, and High-Dose Insulin Euglycemia Therapy 5.2 Digoxin and Cardiac Glycosides: Mechanism, Arrhythmias, and Digoxin Immune Fab 5.3 Sympathomimetics, Cocaine, Amphetamines, Synthetic Cannabinoids, and Hallucinogens 5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants 5.5 Cannabis, GHB, Nitrites, and Nicotine Products

6 Chapter 6: Endocrine, Antimicrobial & Miscellaneous Medications

6.1 Antidiabetic Agents, Metformin Lactic Acidosis, and Thyroid Hormone 6.2 Antimicrobials, Vitamins and Minerals, and Veterinary Products

7 Chapter 7: Household, Chemical & Inhalational Toxins

7.1 Caustic and Corrosive Ingestions: Acids vs. Alkalis, Tissue Necrosis, and Endoscopic Grading 7.2 Cleaning Products, Personal Care Products, and Household Chemicals 7.3 Hydrocarbons and Halogenated Solvents: Aspiration Risks and Myocardial Sensitization 7.4 Carbon Monoxide, Cyanide, Hydrogen Sulfide, and Inhalational Irritants

8 Chapter 8: Pesticides, Heavy Metals & Toxic Alcohols

8.1 Organophosphates, Carbamates, Pyrethroids, and Cholinesterase Antidotes 8.2 Rodenticides, Herbicides, Repellents, and Other Pesticides 8.3 Ethylene Glycol, Methanol, and Isopropanol: Metabolism, Osmolal Gaps, and Fomepizole 8.4 Lead, Mercury, Arsenic, Iron Toxicity, and Chelation Protocols

9 Chapter 9: Toxic Plants, Mushrooms & Foodborne Toxins

9.1 Toxic Plants: Cardiac Glycosides, Anticholinergics, Nicotinics, and Sodium Channel Activators 9.2 Oxalate, Irritant, Hallucinogenic, and Stimulant Plants 9.3 Mushroom Poisoning: Amatoxins, Monomethylhydrazine, Muscarine, and Coprine 9.4 Scombroid, Ciguatera, Tetrodotoxin, Paralytic Shellfish, and Botulism 9.5 Bacterial Foodborne Illness and Food Poisoning Triage

10 Chapter 10: Envenomations & Bites

10.1 North American Pit Vipers (Crotalinae): Envenomation Assessment and Antivenom Management 10.2 Elapid Snakebites (Coral Snakes): Neurotoxicity, Clinical Course, and Antivenin 10.3 Black Widow, Brown Recluse Spiders, and Bark Scorpion Stings 10.4 Hymenoptera Stings, Ticks, and Other Arthropods 10.5 Marine Envenomations: Jellyfish, Stingrays, Catfish, and Lionfish

11 Chapter 11: Clinical Assessment, Toxidromes & Triage

11.1 Recognition of Classic Toxidromes and Vital Sign Pattern Analysis 11.2 Severity Assessment, Exposure Urgency, and Poison Center Telephone Triage Flow 11.3 Home Observation vs. Emergency Department Referral Decision-Making 11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

12 Chapter 12: Decontamination, Antidotes & Elimination

12.1 Gastrointestinal Decontamination: Activated Charcoal, Whole Bowel Irrigation, and Contraindications 12.2 Essential Poison Center Antidotes: Indications, Mechanisms, and Titration Pearls 12.3 Enhanced Elimination: Urinary Alkalinization, MDAC, Hemodialysis, and Hemoperfusion 12.4 Resuscitation and Supportive Care: Seizures, Hyperthermia, and Hemodynamic Shock

13 Chapter 13: Pediatric Poisoning & High-Risk Hazards

13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds 13.2 Button Batteries, Rare-Earth Magnets, and Expandable Foreign Bodies 13.3 Developmental Ingestion Patterns, Liquid Detergent Pods, and Essential Oils

14 Chapter 14: Communication, NPDS Documentation & Prevention

14.1 Emergency Call Communication, Panicked Callers, and Healthcare Provider Consultations 14.2 National Poison Data System (NPDS) Coding Standards and Medical Outcome Categorization 14.3 Scheduled Follow-up Protocols, Medical Toxicologist Consultation Triggers, and Public Health Surveillance 14.4 Evidence-Based Poison Prevention, PPPA Regulations, and Community Outreach

11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

Key Takeaways Explain This Topic AI

High Anion Gap Metabolic Acidosis (HAGMA) calculation (AG = [Na+] - ([Cl-] + [HCO3-]), normal 8–12 mEq/L) structured by the GOLD MARK mnemonic rapidly identifies occult metabolic poisons, while the Delta-Delta ratio (Delta AG / Delta HCO3-) unmasks hidden concurrent metabolic alkalosis or normal anion gap acidosis.

The Serum Osmolal Gap serves as a time-critical screening surrogate for parent toxic alcohols (methanol, ethylene glycol, isopropanol), displaying a reciprocal 'hourglass' relationship over time as parent alcohols disappear and unmeasured toxic organic acids drive an expanding anion gap.

Toxicology electrocardiography identifies myocardial ion channel blockade: QRS prolongation > 100 ms predicts seizure risk and > 160 ms predicts ventricular dysrhythmias in sodium channel blocker poisoning, a terminal 40 ms QRS axis shift in aVR (R ≥ 3 mm or R/S > 0.7) indicates right ventricular conduction delay, and QTc prolongation > 500 ms indicates Torsades de Pointes risk.

Urine Drug Screen (UDS) immunoassays carry profound diagnostic limitations, displaying frequent false-positive cross-reactivity and an inability to detect high-potency synthetic opioids (fentanyl, buprenorphine, methadone), synthetic cathinones, or novel psychoactive substances.

Electrolyte patterns narrow the differential (hyperkalemia with acute digoxin or fluoride, hypokalemia with theophylline or toluene, hypocalcemia with ethylene glycol or hydrofluoric acid), and test selection should be limited to results that change management, led by an acetaminophen concentration, a blood gas with anion gap, and a 12-lead ECG.

Last updated: September 2026

In the management of the poisoned patient, general clinical laboratory testing, 12-lead electrocardiography, and targeted drug assays provide indispensable diagnostic and prognostic data. Rather than relying on non-specific clinical impressions, the Specialist in Poison Information (CSPI) and clinical toxicologist utilize rigorous mathematical models—such as the serum anion gap, delta-delta ratio, and osmolal gap—alongside precise electrophysiological measurements to identify occult toxins, assess life-threatening cellular toxicity, and guide antidotal interventions.

High Anion Gap Metabolic Acidosis (HAGMA) in Toxicology

The serum anion gap measures the balance between routinely measured serum cations and anions, serving as a vital biochemical screening tool for unmeasured endogenous and exogenous toxic acids. Serum Anion Gap Formula: AG = [Na+] - ([Cl-] + [HCO3-])

  • Normal Reference Range: 8 to 12 mEq/L (lab specific, up to 14 mEq/L)
  • Correction for Albumin: Adjusted AG = Observed AG + 2.5 * (4.0 - [Albumin in g/dL])

Because serum albumin accounts for the majority of unmeasured negative charges under normal physiological conditions, severe hypoalbuminemia artificially depresses the baseline anion gap . For every 1.0 g/dL drop in serum albumin below 4.0 g/dL, the baseline anion gap falls by approximately 2.5 mEq/L. Failing to correct for hypoalbuminemia can cause a clinician to miss a significant accumulation of toxic anions.

The Modern Toxicological Mnemonic: GOLD MARK

While the historical mnemonic MUDPILES is widely taught, modern clinical toxicology relies on the GOLD MARK framework, which accounts for contemporary toxicological and metabolic etiologies:

Letter Etiological Entity Biochemical Mechanism & Clinical Context

G Glycols (Ethylene Glycol, Propylene Glycol, Diethylene Glycol) Ethylene glycol metabolizes via alcohol dehydrogenase (ADH) into glycolic, glyoxylic, and oxalic acids , causing acute renal failure and calcium oxalate crystal deposition. Propylene glycol (medication diluent, e.g., IV lorazepam) metabolizes to L- and D-lactic acid .

O Oxoproline (5-Oxoproline / Pyroglutamic Acid) Occurs in chronic therapeutic acetaminophen use in malnourished, critically ill, or septic patients (often women). Glutathione depletion interrupts the gamma-glutamyl cycle, shunting intermediates into 5-oxoproline accumulation.

L L-Lactic Acid Type A (tissue hypoperfusion/shock) or Type B (cellular poisons: cyanide, carbon monoxide, hydrogen sulfide, iron, metformin, antiretrovirals) and excessive muscular activity (status epilepticus).

D D-Lactic Acid Produced by intestinal bacterial fermentation of carbohydrates in patients with short-bowel syndrome or jejunoileal bypass; not detected by routine commercial L-lactate assays.

M Methanol Metabolized via ADH to formaldehyde and formic acid , which inhibits mitochondrial cytochrome c oxidase, causing optic disk hyperemia, retinal edema, 'snowfield' blindness, and putaminal necrosis.

A Aspirin (Salicylates) Salicylic acid is a weak acid, but the profound acidosis is driven primarily by uncoupling of oxidative phosphorylation, generating massive endogenous lactic acid, acetoacetic acid, and beta-hydroxybutyric acid .

R Renal Failure (Uremia) Retention of unmeasured mineral and organic anions (sulfates, phosphates, urate, hippurate) due to reduced glomerular filtration.

K Ketoacidosis Accumulation of acetoacetate and beta-hydroxybutyrate in Diabetic Ketoacidosis (DKA), Alcoholic Ketoacidosis (AKA), and Starvation Ketosis.

The Delta-Delta (Δ - Δ) Ratio: Decoding Mixed Acid-Base Disorders

In complex toxicological presentations, a patient may suffer from multiple concurrent acid-base derangements. The Delta-Delta (Δ AG / Δ HCO₃⁻) ratio compares the excess anion gap above normal to the deficit in serum bicarbonate below normal: Delta-Delta Ratio ( Δ − Δ ) = Δ A G Δ H C O 3 − = Observed A G − 12 24 − [ H C O 3 − ] \text{Delta-Delta Ratio } (\Delta - \Delta) = \frac{\Delta AG}{\Delta HCO_3^-} = \frac{\text{Observed } AG - 12}{24 - [HCO_3^-]} Delta-Delta Ratio ( Δ − Δ ) = Δ H C O 3 − ​ Δ A G ​ = 24 − [ H C O 3 − ​ ] Observed A G − 12 ​

Ratio Between 1.0 and 2.0 (Pure HAGMA): For every 1 mEq/L increase in unmeasured toxic anions, exactly 1 mEq/L of bicarbonate is consumed in buffering. Typical of pure diabetic ketoacidosis or early, uncomplicated toxic alcohol ingestions.

Ratio < 1.0 (typically < 0.4 to 0.8) (Mixed HAGMA + Normal Anion Gap Metabolic Acidosis): The drop in bicarbonate is disproportionately greater than the rise in the anion gap. Common in toluene / volatile solvent abuse (hippuric acid excretion causes hyperchloremic NAGMA), toxic diarrhea, or underlying renal tubular acidosis.

Ratio > 2.0 (Mixed HAGMA + Metabolic Alkalosis): The serum bicarbonate is substantially higher than predicted for the degree of anion gap elevation. Classically observed in acute salicylate poisoning where persistent, violent vomiting causes hydrochloric acid and gastric volume loss (metabolic alkalosis) superimposed upon severe salicylate-induced high anion gap acidosis.

The Serum Osmolal Gap in Toxicology

The serum osmolal gap evaluates the presence of low-molecular-weight, osmotically active xenobiotics circulating in the bloodstream before significant metabolic degradation has occurred. Calculated Serum Osmolality Formula (Conventional Units in mg/dL):

Calculated Osm = 2 * [Na+] + (Glucose / 18) + (BUN / 2.8) + (Ethanol / 4.6)

Serum Osmolal Gap Formula:

  • Osmolal Gap = Measured Serum Osmolality - Calculated Serum Osmolality
  • Normal Reference Range: -10 to +10 mOsm/kg (clinical suspicion raised if > 10–14 mOsm/kg)
  • Critical Analytical Pitfall: Freezing Point Depression vs. Vapor Pressure

When ordering measured serum osmolality for suspected toxic alcohol ingestions, the laboratory must use a freezing point depression osmometer . Volatile alcohols (methanol, ethanol, isopropanol) vaporize into the gas phase during vapor pressure osmometry, resulting in a falsely normal measured osmolality and a completely masked, falsely normal osmolal gap.

The Reciprocal 'Hourglass' Phenomenon: Osmolal Gap vs. Anion Gap

Understanding the temporal evolution of toxic alcohol metabolism is one of the most critical concepts in clinical toxicology: Early Post-Ingestion (0–4 Hours): HIGH Osmolal Gap | NORMAL Anion Gap (Parent alcohol intact)

  • Intermediate Phase (6–12 Hours): FALLING Osm Gap | RISING Anion Gap (Metabolism underway)
  • Late Presentation (> 12–24 Hours): NORMAL Osm Gap | MASSIVE Anion Gap (Parent alcohol exhausted)

Early Phase: Immediately following ingestion of methanol or ethylene glycol, the parent compound circulates unmetabolized in high concentrations. Because the parent alcohols are electrically neutral, the osmolal gap is markedly elevated , while the anion gap remains completely normal .

Metabolic Conversion: Hepatic alcohol dehydrogenase (ADH) and aldehyde dehydrogenase metabolize the parent alcohols into small organic acids (glycolic/oxalic acid for ethylene glycol; formic acid for methanol).

Late Phase: As parent molecules are consumed, the osmolal gap closes back into the normal range , while unmeasured anionic metabolites accumulate, driving an enormous high anion gap metabolic acidosis .

Clinical Triage Warning: A completely normal osmolal gap in a patient presenting 18 hours after an ingestion does NOT rule out ethylene glycol or methanol toxicity . By that time, all parent alcohol has been metabolized into lethal organic acids, and the patient will present in profound metabolic acidosis with renal failure or optic injury.

The Isopropanol Exception: Ketosis Without Acidosis

Isopropanol (rubbing alcohol) is metabolized by alcohol dehydrogenase into acetone , which is a ketone rather than an acid. Consequently, isopropanol toxicity presents with an elevated osmolal gap, ketonemia, and ketonuria WITHOUT metabolic acidosis (normal anion gap and normal serum bicarbonate), accompanied by marked central nervous system depression and hemorrhagic gastritis.

Toxicology Electrocardiography (ECG)

The 12-lead ECG is an instantaneous, non-invasive window into myocardial ion channel function, alerting clinicians to life-threatening cardiotoxicity before overt dysrhythmias develop.

1. Myocardial Sodium Channel Blockade (Phase 0 Depolarization)

Numerous xenobiotics block cardiac fast voltage-gated sodium channels (Nav1.5), slowing Phase 0 of the cardiac action potential and prolonging intraventricular conduction.

Offending Agents: Tricyclic antidepressants (TCAs: amitriptyline, nortriptyline), Type Ia and Ic antiarrhythmics (quinidine, procainamide, flecainide), diphenhydramine, cocaine, propoxyphene, chloroquine, and carbamazepine.

Electrocardiographic Hallmarks:

QRS Interval Widening: Measured in the limb leads.

QRS > 100 ms: Associated with an approximate 33% risk of generalized seizures .

QRS > 160 ms: Associated with an approximate 50% risk of life-threatening ventricular dysrhythmias (monomorphic ventricular tachycardia, ventricular fibrillation).

Terminal 40 ms QRS Axis Shift in Lead aVR: Because the right bundle branch and basal right ventricular septum are particularly sensitive to conduction delay, the terminal electrical vector shifts rightward and superiorly into lead aVR:

Prominent terminal R wave in aVR ≥ 3 mm .

R/S ratio in aVR > 0.7 .

Therapeutic Intervention: Immediate administration of hypertonic sodium bicarbonate (1 to 2 mEq/kg IV push bolus), which acts via two distinct mechanisms: (1) flooding extracellular space with high sodium concentrations ([Na⁺] ≈ 1000 mEq/L in 8.4% solutions) to overcome competitive channel block, and (2) systemic alkalinization (targeting blood pH 7.45 to 7.55), which shifts the drug into an un-ionized conformation, detaching it from the sodium channel binding site.

2. Potassium Channel (IKr) Blockade and QTc Prolongation

Xenobiotics that block rapid delayed rectifier potassium channels (IKr, encoded by the hERG gene) impair Phase 3 myocardial repolarization, manifesting as marked QTc interval prolongation .

Offending Agents: Methadone, citalopram, escitalopram, antipsychotics (haloperidol, ziprasidone, quetiapine), sotalol, quinolones, and macrolides.

Clinical Thresholds: QTc intervals > 500 ms (calculated using Bazett's formula or Fridericia's correction) substantially increase the risk of degenerating into Torsades de Pointes (TdP) and ventricular fibrillation.

Management: Correct hypokalemia (maintain serum K⁺ > 4.0 to 4.5 mEq/L) and hypomagnesemia (Mg²⁺ > 2.0 mg/dL). For active TdP or recurrent pauses, administer intravenous magnesium sulfate (2 g IV over 1–2 minutes) and initiate overdrive transvenous or pharmacological (isoproterenol) pacing to maintain heart rate > 90 to 100 bpm.

Urine Drug Screens (UDS): Immunoassays, False-Positives, and Blind Spots

Point-of-care and laboratory-based urine drug screens rely on immunoassays such as EMIT, CEDIA, and KIMS. Antibodies in the reagent are engineered to bind a specific parent drug or major metabolite. Because these antibodies rely on structural shape-matching, they are plagued by cross-reactivity and false-negative 'blind spots'.

1. Common False-Positive Cross-Reactions

Immunoassay Panel Target Calibrator Compound Cross-Reacting Pharmaceuticals Causing False Positives

Amphetamines / Methamphetamine d-Amphetamine / Methamphetamine Bupropion (Wellbutrin) , pseudoephedrine, phenylephrine, labetalol, ranitidine, trazodone, chlorpromazine, metformin (rarely)

Opioids (Opiate Screen) Morphine (300 or 2000 ng/mL) Dextromethorphan , poppy seed ingestion, fluoroquinolones (ofloxacin, levofloxacin), rifampin, diphenhydramine (high concentrations)

Phencyclidine (PCP) Phencyclidine Dextromethorphan , venlafaxine (Effexor) , tramadol, lamotrigine, diphenhydramine, ketamine (rarely)

Benzodiazepines Oxazepam Sertraline (Zoloft) , oxaprozin (Daypro), efavirenz

Cannabinoids (THC) 11-nor-delta-9-THC-COOH Pantoprazole (Protonix), NSAIDs (ibuprofen, naproxen historically), dronabinol, hemp seed products

Tricyclic Antidepressants Desipramine / Amitriptyline Diphenhydramine , quetiapine, carbamazepine, cyclobenzaprine, cyproheptadine

2. The Critical Synthetic Blind Spot: False Negatives

A critical tenet of clinical toxicology is that a negative routine urine drug screen never excludes severe opioid or sedative-hypnotic poisoning :

The Opioid Immunoassay: Calibrated specifically against morphine . It reliably detects natural opiates (morphine, codeine) and the semi-synthetic heroin metabolite (6-monoacetylmorphine). However, it CANNOT DETECT SYNTHETIC OPIOIDS : fentanyl , fentanyl analogues, methadone , buprenorphine , tramadol , or meperidine. A patient dying of a fatal fentanyl overdose will have a completely negative routine opiate urine drug screen!

The Benzodiazepine Immunoassay: Calibrated against oxazepam . It reliably detects drugs that metabolize to oxazepam (diazepam, chlordiazepoxide, temazepam). It frequently misses lorazepam, clonazepam, alprazolam , and novel designer benzodiazepines because their metabolites lack sufficient cross-reactivity with the antibody.

Novel Psychoactive Substances (NPS): Synthetic cathinones ('bath salts'), synthetic cannabinoids ('K2/Spice'), hallucinogenic phenethylamines (2C-I, NBOMe), and xylazine are completely invisible on standard urine drug immunoassays, requiring specialized gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) for confirmation.

Poison Center Case Scenario: The Acidotic Comatose Patient

A 45-year-old male with a history of alcohol use disorder is found unresponsive on the floor of his garage and brought to the emergency department. On arrival, he is comatose (GCS 6), intubated for airway protection, and breathing on a mechanical ventilator. Vital signs: blood pressure 102/60 mmHg, heart rate 108 bpm, temperature 36.2°C. The 12-lead ECG reveals a normal sinus tachycardia with QRS duration 88 ms and QTc 440 ms.

Laboratory Data Received

Electrolytes & Chemistries: Sodium 140 mEq/L, Potassium 4.8 mEq/L, Chloride 98 mEq/L, Bicarbonate 10 mEq/L, BUN 14 mg/dL, Serum Creatinine 1.8 mg/dL, Glucose 90 mg/dL, Serum Albumin 4.0 g/dL.

Blood Gas: pH 7.14, pCO₂ 28 mmHg, pO₂ 95 mmHg, HCO₃⁻ 9.5 mEq/L.

Toxicology Screen: Ethanol level 0 mg/dL. Routine urine drug screen is completely negative.

Serum Osmolality (by Freezing Point Depression): 335 mOsm/kg.

Specialist in Poison Information Consultation Analysis

High Anion Gap Calculation: A G = [ N a + ] − ( [ C l − ] + [ H C O 3 − ] ) = 140 − ( 98 + 10 ) = 32 mEq/L AG = [Na^+] - ([Cl^-] + [HCO_3^-]) = 140 - (98 + 10) = \mathbf{32\text{ mEq/L}} A G = [ N a + ] − ([ C l − ] + [ H C O 3 − ​ ]) = 140 − ( 98 + 10 ) = 32 mEq/L This represents a severe High Anion Gap Metabolic Acidosis (normal 8–12 mEq/L).

Delta-Delta (Δ - Δ) Analysis: Δ A G = 32 − 12 = 20 \Delta AG = 32 - 12 = 20 Δ A G = 32 − 12 = 20 Δ H C O 3 − = 24 − 10 = 14 \Delta HCO_3^- = 24 - 10 = 14 Δ H C O 3 − ​ = 24 − 10 = 14 Δ − Δ = 20 / 14 = 1.43 \Delta - \Delta = 20 / 14 = \mathbf{1.43} Δ − Δ = 20/14 = 1.43 A ratio between 1.0 and 2.0 confirms a pure, unmixed high anion gap metabolic acidosis .

Calculated Osmolality and Osmolal Gap: Calculated Osm = 2 ( 140 ) + 90 18 + 14 2.8 + 0 = 280 + 5 + 5 = 290 mOsm/kg \text{Calculated Osm} = 2(140) + \frac{90}{18} + \frac{14}{2.8} + 0 = 280 + 5 + 5 = 290\text{ mOsm/kg} Calculated Osm = 2 ( 140 ) + 18 90 ​ + 2.8 14 ​ + 0 = 280 + 5 + 5 = 290 mOsm/kg Osmolal Gap = 335 − 290 = 45 mOsm/kg \text{Osmolal Gap} = 335 - 290 = \mathbf{45\text{ mOsm/kg}} Osmolal Gap = 335 − 290 = 45 mOsm/kg An osmolal gap of 45 mOsm/kg (normal < 10 mOsm/kg) confirms the presence of a high concentration of an unmeasured, low-molecular-weight osmotically active toxic alcohol.

Diagnostic Synthesis and Immediate Interventions: The combination of a massive Osmolal Gap (45 mOsm/kg) and a massive High Anion Gap Metabolic Acidosis (32 mEq/L) with acute renal impairment (1.8 mg/dL) points directly to severe ethylene glycol poisoning (or methanol). The CSPI directs the immediate administration of fomepizole (15 mg/kg IV loading dose), urgent emergent hemodialysis , systemic intravenous sodium bicarbonate infusion, and intravenous thiamine and pyridoxine supplementation.

Electrolyte Patterns and Choosing the Right Tests

Two official objectives ask the specialist to name the causative agent from an abnormal electrolyte panel and to decide which laboratory or ancillary tests should be obtained. Both are pattern-recognition tasks.

Electrolyte Clues

Abnormality Toxicologic Causes Mechanism

Hyperkalemia Acute digoxin or plant cardenolide, fluoride, potassium supplements, ACE inhibitors and potassium-sparing diuretics, rhabdomyolysis, succinylcholine in a susceptible patient Na⁺/K⁺-ATPase inhibition, cellular release, impaired excretion

Hypokalemia Theophylline and caffeine, beta-2 agonists, barium, toluene (distal renal tubular acidosis), thiazide and loop diuretics, chloroquine, insulin, licorice Intracellular shift or renal loss

Hypocalcemia Ethylene glycol (oxalate), hydrofluoric acid and fluoride, citrate from massive transfusion, phosphate enemas Chelation and precipitation

Hypercalcemia Vitamin D and cholecalciferol rodenticide, vitamin A, thiazides, calcium supplements Increased absorption and resorption

Hypernatremia Salt ingestion, sodium bicarbonate therapy, lithium-induced nephrogenic diabetes insipidus Sodium load or free water loss

Hyponatremia MDMA (drug-induced SIADH plus water intoxication), carbamazepine and oxcarbazepine, thiazides, psychogenic water intoxication Water retention

Hypomagnesemia and hypophosphatemia Theophylline, caffeine, alcohol use, diuretics, refeeding Shift and renal loss

Hypoglycemia Sulfonylureas, insulin, ethanol in children, beta-blockers (especially propranolol), salicylates, quinine, valproate, adrenal insufficiency Insulin release, impaired gluconeogenesis

Hyperglycemia Calcium channel blockers, theophylline and caffeine, glucocorticoids, olanzapine, iron, organophosphate poisoning Impaired insulin release or catecholamine excess

Blood Findings That Point to an Agent

Two more official objectives ask the specialist to name the likely agent from a coagulopathy and to recognize the methemoglobinemia syndrome.

Finding Toxicologic Causes Clue or Next Step

Coagulopathy (elevated INR or bleeding) Warfarin and long-acting anticoagulant rodenticides (brodifacoum), hepatic failure from acetaminophen or amatoxin, iron, crotaline venom (consumptive coagulopathy with low fibrinogen and platelets), heparin and direct oral anticoagulants, salicylates in large overdose A normal early INR does not exclude a superwarfarin, so recheck at 48 to 72 hours; low fibrinogen and platelets after a snakebite point to venom-induced consumption

Methemoglobinemia Benzocaine and prilocaine, dapsone, nitrites and nitrates (including well water in infants), phenazopyridine, aniline dyes, naphthalene, primaquine, rasburicase Cyanosis that does not improve with oxygen, chocolate-brown blood, pulse oximetry near 85%, and a normal arterial oxygen tension; confirm with co-oximetry and treat symptomatic patients with methylene blue 1 to 2 mg/kg

Hemolysis Oxidant drugs in G6PD deficiency, naphthalene, arsine gas, copper sulfate, bromates, viscerocutaneous loxoscelism, massive Hymenoptera envenomation Check hemoglobin, bilirubin, haptoglobin, and urine for hemoglobin; protect the kidneys

Elevated carboxyhemoglobin Carbon monoxide, methylene chloride (delayed rise) Standard pulse oximetry reads normal; use co-oximetry

Choosing Tests Rather Than Ordering Everything

Test When It Changes Management

Acetaminophen concentration Every intentional overdose, every unknown ingestion, and any acute exposure at or above 150 mg/kg; drawn at 4 hours or later

Salicylate concentration Any suspected salicylate exposure, unexplained acid-base disorder, tinnitus, or altered mental status in an older adult; serial levels until falling

Blood gas (arterial or venous) Any patient with altered mental status, tachypnea, hypotension, or suspected toxic alcohol, salicylate, cyanide, or carbon monoxide exposure

  • Electrolytes with calculated anion gap Essentially all symptomatic poisonings
  • Measured osmolality (freezing point) Suspected toxic alcohol, especially early after ingestion

Lactate Suspected cyanide, carbon monoxide, metformin, massive acetaminophen, or shock of any cause; a marked point-of-care to laboratory lactate discrepancy suggests ethylene glycol

Co-oximetry Suspected carbon monoxide or methemoglobinemia; standard pulse oximetry cannot detect either

ECG (12-lead) Any cardioactive drug, any unknown overdose, any tricyclic or antipsychotic exposure; repeat serially when a level is rising

  • Creatine kinase Agitation, prolonged immobility, seizures, hyperthermia, or muscle pain
  • INR and hepatic panel Acetaminophen, amatoxin, superwarfarin, iron, and any patient with hepatic symptoms

Abdominal radiograph Radiopaque ingestions: iron, heavy metals, some sustained-release tablets, halogenated hydrocarbons, button batteries, drug packets

Specific drug concentrations (lithium, digoxin, theophylline, valproate, carbamazepine, phenytoin, iron, ethanol, methanol, ethylene glycol, carboxyhemoglobin) When the level guides an antidote, dialysis, or observation decision

Urine drug immunoassay Rarely changes acute management and carries false positives and negatives; a comprehensive screen is generally reserved for unexplained presentations

Ordering principle: request a test when the result will change what you do in the next few hours. A confirmatory comprehensive drug screen almost never meets that standard; an acetaminophen level, a blood gas, an anion gap, and an ECG almost always do.

Loading diagram... Reciprocal Temporal Evolution: Osmolal Gap vs. Anion Gap in Toxic Alcohols